MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    University Hospital Vienna  
 
phd_immunology.png
 
 
Hauptnavigation
  • Home
  • General Information
  • Research Laboratories
  • PhD Students
  • Lectures & Courses
 
PhD Immunologie / Research Laboratories /
 
Subnavigation
    Inhaltsbereich

    Verena Niederberger-Leppin, MD

    Associate Professor of Otorhinolaryngology

    ENT-Department, 8J, AKH
    Medical University of Vienna
    Währinger Gürtel 18-20, A-1090 Vienna, Austria

    Phone: +43 (0)1 40400 - 34380
    FAX: +43 (0)1 25330 - 338567


    E-Mail: verena.niederberger@meduniwien.ac.at

     

    Research Interests
    Clinical allergy and allergen immunotherapy, translational Research in Allergy, innovative clinical trials for allergy treatment, respiratory airways, IgE production, IgE receptors.

     

    Abstract

    Being based at an ENT department, our group has a long-term research interest in the upper respiratory airways as a site for IgE production and the regulation of the IgE response. In this context we are investigating different factors which are able to influence the permeability of the respiratory epithelium for allergens.
    Furthermore, we are currently studying various aspects of CD23, the low-affinity IgE receptor, which plays an important role in IgE-facilitated allergen binding (FAB) and presentation to T cells, and has also been described to play a role in IgE regulation. Another research topic is the characterization and diagnostic use of allergen components and we are performing various clinical trials in allergic patients as a major part of our scientific work. For example we were involved in the first allergen immunotherapy study with genetically modified recombinant allergens.

     
    Print
     

    Quick Links

     
    -- Contact
    -- Center for Pathophysiology, Infectiology and Immunology

    -- Intranet Login
     
     

    Featured

     
     
     
     
     
    © MedUni Wien  | 
     Publishing information | Terms of use | Accessibility | Contact